NEW YORK (GenomeWeb News) – Shares of Caliper Life Sciences closed down more than 12 percent in Monday trade on the Nasdaq in advance of the release of its second-quarter results on Wednesday.
 
As reported Friday by GenomeWeb Daily News, Caliper’s stock had gained around 53 percent in the month of July, after it had declined steadily through the first half of the year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.